• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 4 filed by Wickes Gene H

    1/12/22 3:59:48 PM ET
    $WLTW
    Specialty Insurers
    Finance
    Get the next $WLTW alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
    1. Name and Address of Reporting Person*
    WICKES GENE H

    (Last) (First) (Middle)
    C/O WILLIS GROUP LIMITED
    51 LIME STREET

    (Street)
    LONDON X0 EC3M 7DQ

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    WILLIS TOWERS WATSON PLC [ WLTW ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director 10% Owner
    X Officer (give title below) Other (specify below)
    Head of Benefits Deliv & Admin
    3. Date of Earliest Transaction (Month/Day/Year)
    01/10/2022
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Restricted Share Unit (1) 01/10/2022 A 42.0879(2) (1) (1) Ordinary Shares, nominal value $0.000304635 per share 42.0879 $232.62 24,363.9351 D
    Restricted Share Unit (1) 01/10/2022 A 24.5514(3) (1) (1) Ordinary Shares, nominal value $0.000304635 per share 24.5514 $0 24,388.4865 D
    Explanation of Responses:
    1. Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.
    2. Includes restricted share units acquired pursuant to the participant's deferral election under the Willis Towers Watson Non-Qualified Deferred Savings Plan for U.S. Employees (the "Plan").
    3. Includes restricted share units acquired pursuant to the Company's matching contribution on the participant's deferral election pursuant to the terms of the Plan and credited to the participant's account in the form of restricted share units under the Plan.
    /s/ Gene H. Wickes by Elaine Wiggins, Attorney-in-Fact (power of attorney previously filed) 01/12/2022
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $WLTW alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $WLTW

    DatePrice TargetRatingAnalyst
    1/4/2022$280.00 → $284.00Overweight
    Wells Fargo
    12/16/2021$240.00In-Line
    Evercore ISI Group
    11/19/2021$258.00Hold
    Jefferies
    10/29/2021$266.00 → $280.00Overweight
    Wells Fargo
    10/20/2021$283.00 → $244.00Outperform → Peer Perform
    Wolfe Research
    9/10/2021$250.00 → $285.00Buy
    MKM Partners
    9/10/2021$220.00 → $235.00Neutral
    Piper Sandler
    8/17/2021$261.00Outperform
    Wolfe Research
    More analyst ratings

    $WLTW
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Banas Kristy D

      4 - WILLIS TOWERS WATSON PLC (0001140536) (Issuer)

      1/12/22 4:05:45 PM ET
      $WLTW
      Specialty Insurers
      Finance
    • SEC Form 4 filed by Qureshi Imran Ahmed

      4 - WILLIS TOWERS WATSON PLC (0001140536) (Issuer)

      1/12/22 4:04:51 PM ET
      $WLTW
      Specialty Insurers
      Finance
    • SEC Form 4 filed by Kurpis Joseph Stephen

      4 - WILLIS TOWERS WATSON PLC (0001140536) (Issuer)

      1/12/22 4:04:07 PM ET
      $WLTW
      Specialty Insurers
      Finance

    $WLTW
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Horizon Therapeutics plc Launches #RAREis Representation Program to Elevate Global Rare Disease Equity

      -- The new program and website are designed to create conversations that will lead to new resources to support diversity, equity, inclusion and allyship within the rare disease community -- -- #RAREis webcast conversation with The Akari Foundation, Amigos Múltiplos, Child Neurology Foundation and The Sumaira Foundation to be held on Feb. 28 at 8:55 a.m. CT -- Horizon Therapeutics plc (NASDAQ:HZNP) today announced the launch of the #RAREis Representation program, which expands Horizon's #RAREis program to support advancing global equity in the rare disease community. The program is centered around a new section of the #RAREis website where individuals are invited to provide feedback via a

      2/28/22 9:00:00 AM ET
      $HZNP
      $WLTW
      Biotechnology: Pharmaceutical Preparations
      Health Care
      Specialty Insurers
      Finance
    • WTW celebrates new name and Nasdaq ticker symbol with market opening ceremony

      ARLINGTON, Va., Jan. 25, 2022 (GLOBE NEWSWIRE) -- Following the recent announcement by Willis Towers Watson to rebrand as WTW, combined with the company's new Nasdaq ticker symbol (NASDAQ:WTW), the company today led Nasdaq's market opening bell ringing ceremony.   Speaking from the Nasdaq podium, WTW CEO, Carl Hess, said, "Since 2016 we have been known as Willis Towers Watson, the combination of Willis and Towers Watson. Now we move forward as WTW, both a celebration of our rich history and the promise of our unified future as One WTW. "I'm incredibly proud of the progress we've made as a company, under the banner of different names throughout our remarkable history. Today WTW is

      1/25/22 7:45:00 AM ET
      $WLTW
      $WTW
      Specialty Insurers
      Finance
    • WTW to Announce Fourth Quarter and Full Year Earnings on February 8, 2022

      ARLINGTON, Va. and LONDON, Jan. 13, 2022 (GLOBE NEWSWIRE) -- WTW ((Willis Towers Watson, NASDAQ:WTW), a leading global advisory, broking and solutions company, will announce its financial results for the fourth quarter and full year on Tuesday February 8, 2022 before the market opens. The company will host a conference call to discuss its financial results at 9:00 a.m. Eastern Time on February 8, 2022. A live broadcast of the conference call will be available online at the Investor Relations section of www.wtwco.com. An online replay at www.wtwco.com will be available shortly after the call. A telephonic replay of the call will also be available for 24 hours at 404-537-3406, conference I

      1/13/22 4:00:00 PM ET
      $WLTW
      Specialty Insurers
      Finance

    $WLTW
    SEC Filings

    See more
    • Willis Towers Watson Public Limited Company filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

      8-K - WILLIS TOWERS WATSON PLC (0001140536) (Filer)

      1/7/22 8:31:00 AM ET
      $WLTW
      Specialty Insurers
      Finance
    • Willis Towers Watson Public Limited Company filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

      8-K - WILLIS TOWERS WATSON PLC (0001140536) (Filer)

      12/30/21 4:28:02 PM ET
      $WLTW
      Specialty Insurers
      Finance
    • Willis Towers Watson Public Limited Company filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

      8-K - WILLIS TOWERS WATSON PLC (0001140536) (Filer)

      12/10/21 4:00:57 PM ET
      $WLTW
      Specialty Insurers
      Finance

    $WLTW
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Wells Fargo reiterated coverage on Willis Towers Watson with a new price target

      Wells Fargo reiterated coverage of Willis Towers Watson with a rating of Overweight and set a new price target of $284.00 from $280.00 previously

      1/4/22 8:57:03 AM ET
      $WLTW
      Specialty Insurers
      Finance
    • Evercore ISI Group initiated coverage on Willis Towers Watson with a new price target

      Evercore ISI Group initiated coverage of Willis Towers Watson with a rating of In-Line and set a new price target of $240.00

      12/16/21 6:36:03 AM ET
      $WLTW
      Specialty Insurers
      Finance
    • Jefferies initiated coverage on Willis Towers Watson with a new price target

      Jefferies initiated coverage of Willis Towers Watson with a rating of Hold and set a new price target of $258.00

      11/19/21 5:04:38 AM ET
      $WLTW
      Specialty Insurers
      Finance